Jang‐June Park

ORCID: 0000-0002-6286-7780
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • T-cell and B-cell Immunology
  • Hepatitis C virus research
  • CAR-T cell therapy research
  • Hepatitis B Virus Studies
  • Caveolin-1 and cellular processes
  • Liver Disease Diagnosis and Treatment
  • Cancer Mechanisms and Therapy
  • Mechanisms of cancer metastasis
  • Cancer Immunotherapy and Biomarkers
  • Cell Adhesion Molecules Research
  • Glycosylation and Glycoproteins Research
  • Reproductive System and Pregnancy
  • NF-κB Signaling Pathways
  • Peptidase Inhibition and Analysis
  • Lymphoma Diagnosis and Treatment
  • Protein Tyrosine Phosphatases
  • Histone Deacetylase Inhibitors Research
  • Hepatitis Viruses Studies and Epidemiology
  • Veterinary Oncology Research
  • Sphingolipid Metabolism and Signaling
  • Complement system in diseases
  • Immune Response and Inflammation
  • Cancer Cells and Metastasis

Hepatitis B Foundation
2023

Research Network (United States)
2023

University of Pennsylvania
2014-2019

Philadelphia VA Medical Center
2015-2019

Philadelphia University
2014

Henry Ford Health System
2011-2013

University of Maryland, Baltimore
2010-2013

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
2010-2011

Sidney Kimmel Comprehensive Cancer Center
2009

Vanderbilt University
2003-2004

Abstract Programmed death-ligand 1 is a glycoprotein expressed on antigen presenting cells, hepatocytes, and tumors which upon interaction with programmed death-1, results in inhibition of antigen-specific T cell responses. Here, we report mechanism inhibiting through small molecule-induced dimerization internalization. This represents checkpoint inhibition, differentiates from anti-programmed antibodies function molecular disruption the death interaction. Testing ligand molecule humanized...

10.1038/s41467-021-21410-1 article EN cc-by Nature Communications 2021-02-22

Va14Ja18 natural T (NKT) cells play an immunoregulatory role, which is controlled by a self glycolipid(s) presented CD1d. Although the synthetic antigen α-D-galactosylceramide (α-D-GalCer) stimulates all NKT cells, α-anomeric D-glycosylceramides are currently unknown in mammals. We have used β-D-GalCer-deficient mice and β-D-glucosylceramide (β-D-GlcCer)-deficient to define chemical nature of cell antigen. exhibit normal development function, from these animals potently stimulate hybridomas....

10.1073/pnas.0430327100 article EN Proceedings of the National Academy of Sciences 2003-02-07
Marc G. Ghany Robert Perrillo Ruosha Li Steven H. Belle Harry L.A. Janssen and 95 more Norah A. Terrault Margaret C. Shuhart Daryl Lau W. Ray Kim Michael Fried Richard K. Sterling Adrian M. Di Bisceglie Steven–Huy B. Han Lilia Milkova Ganova-Raeva Kyong-Mi Chang Anna Suk-Fong Lok Raymond Chung Lewis R. Roberts Coleman Smith Mauricio Lisker‐Melman David Wong Joshua Juan Jordan J. Feld Colina Yim Jenny Heathcoate William M. Lee Do Ngoc Son Tram T. Tran Mandana Khalili Stewart Cooper Robert J. Fontana Naoky Tsai Keyur P. Patel Donna M. Evon Robert C. Carithers Kris V. Kowdley Chia C. Wang T. Jake Liang Jang‐June Park Abdus S. Wahed David E. Kleiner Nezam H. Afdhal Asad Javaid Jianghe Niu Johanna Han Imad Nasser Alisha C. Stahler Linda Stadheim Mohamed Hassan Debra King Rosemary A. Nagy Danie La Lucie Liu Stacey Minshall Sheila Bass Samuel W. French Velma Peacock Ashley Ungermann Claudia P. Ayala Emma Olson Ivy Lau Veronika Podolskaya Nata DeVole Barbara J. McKenna Kelly Oberhelman Sravanthi Kaza Cassandra Rodd Leslie Huddleston Peter Poerzgen Jama M. Darling A. Sidney Barritt Tiffany Marsh Vikki Metheny Danielle Cardona Velimir A. Luketic Paula G. Smith Charlotte M. Hofmann T. L. Mathisen Susan Strom Jody Mooney Lupita Cardona-Gonzalez Nancy Fryzek Elenita Rivera Nevitt Morris Vanessa Haynes–Williams Mary E. Valiga Keith Torrey Danielle Levine James C. Keith Michael R. Betts Luis J. Montaner Chong‐Gee Teo Yury Khudyakov Lili Punkova Yona Keich Cloonan Michelle E. Danielson Tamara Haller Geoffrey Johnson Stephanie Kelley Sharon Lawlor

10.1016/j.cgh.2014.06.028 article EN Clinical Gastroenterology and Hepatology 2014-07-08

Abstract Chronic hepatitis B (CHB) infection functional cure is defined as sustained loss of HBsAg and several therapeutic strategies are in clinical development designed to pharmacologically reduce serum HBsAg, break immune tolerance, increase rates. However, little known about pre-treatment levels an indicator HBV potential. Here, we compared the phenotypes HBV-specific response lymphocytes CHB patients stratified by <500 (HBs lo ) or >50,000 IU/ml hi using immunological assays (flow...

10.1038/s41598-020-58870-2 article EN cc-by Scientific Reports 2020-02-04

Abstract Ontogenetic, homeostatic, and functional deficiencies within immunoregulatory natural T (iNKT) lymphocytes underlie various inflammatory immune disorders including autoimmunity. Signaling events that control cell fate specification molecular differentiation of iNKT cells are only partly understood. Here we demonstrate these processes require classical NF-κB signaling. Inhibition signaling blocks ontogeny at an immature stage reveals apparent, novel precursor in which negative...

10.4049/jimmunol.172.4.2265 article EN The Journal of Immunology 2004-02-15

Abstract Cancers display distinct patterns of organ-specific metastasis. Comparative analysis a broad array cell membrane molecules on liver-metastasizing subline B16 melanoma versus the parental B16-F0 revealed unique up-regulation integrin α2. The direct role α2 in hepatic metastasis was shown by comparison high low-expressing populations, antibody blockade, and ectopic expression. Integrin α2–mediated binding to collagen type IV (highly exposed liver sinusoids) IV–dependent activation...

10.1158/0008-5472.can-09-0315 article EN Cancer Research 2009-09-09

ErbB3 is markedly overexpressed in breast cancer cells and associated with resistance metastasis. Additionally, expression levels are positively correlated low densities of tumor-infiltrating lymphocytes, a marker poor prognosis. Consequently, promising therapeutic target for immunotherapy. Here, we report the generation ErbB3-targeted chimeric antigen receptor (CAR)-modified natural killer (NK) by transducing cord blood-derived primary NK using vsv-g envelope-pseudotyped lentiviral vectors....

10.1007/s00262-024-03923-y article EN cc-by-nc-nd Cancer Immunology Immunotherapy 2025-01-03

Abstract Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that accompanied by the emergence of autoreactive T cells and reduction in regulatory cells. Humans mice with SLE have reduced numbers CD1d-restricted NK cells, suggesting role for these regulation SLE. In this study, we show CD1d deficiency exacerbates nephritis induced hydrocarbon oil pristane. This exacerbation associated with: 1) TNF-α IL-4 production especially during induction phase; 2) expansion marginal zone...

10.4049/jimmunol.171.4.2142 article EN The Journal of Immunology 2003-08-15

Abstract The rapid and robust immunoregulatory cytokine response of Va14Ja18 natural T (iNKT) cells to glycolipid Ags determines their diverse functions. Unlike conventional cells, iNKT lymphocyte ontogeny absolutely requires NF-κB signaling. However, the precise role in cell function identity upstream signals that activate this subset remain unknown. Using mice which has been rescued despite inhibition signaling, we demonstrate a lymphocyte-intrinsic manner. Furthermore, functional...

10.4049/jimmunol.172.8.4667 article EN The Journal of Immunology 2004-04-15

The CD1 family consists of lipid antigen-presenting molecules, which include group I CD1a, CD1b, and CD1c II CD1d proteins. Topologically, they resemble the classical peptide MHC molecules except that large, exclusively nonpolar hydrophobic, antigen-binding groove has evolved to present cellular pathogen-derived antigens specific T lymphocytes. As an approach understanding biochemical basis antigen presentation by we have characterized natural ligands associated with mouse CD1d1 as well...

10.1073/pnas.0307847100 article EN Proceedings of the National Academy of Sciences 2004-01-13

Disparities in treatment initiation may affect outcomes, but data on racially diverse populations with chronic hepatitis B virus (HBV) infection are limited.To examine whether HBV and outcomes differ among racial groups.From January 14, 2011, to 28, 2018, surface antigen-positive adults (age ≥18 years) not receiving anti-HBV therapy were enrolled followed up at weeks 12, 24, every 24 thereafter a multicenter longitudinal cohort study (Hepatitis Research Network [HBRN] adult study) conducted...

10.1001/jamanetworkopen.2023.7018 article EN cc-by-nc-nd JAMA Network Open 2023-04-10

Hepatitis B virus (HBV) persists with global and virus-specific T-cell dysfunction, without based correlates of outcomes. To determine if γδT-cells are altered in HBV infection relative to clinical status, we examined the frequency, phenotype function peripheral blood Vδ1+ Vδ2+γδT-cells by multi-parameter cytometry a clinically diverse North American cohort chronic hepatitis (CHB), acute (AHB) uninfected control subjects. We show that circulating were comprised predominantly CD3hiCD4-...

10.1371/journal.ppat.1007715 article EN public-domain PLoS Pathogens 2019-04-18

Programmed death ligand-1 (PD-L1) is an important negative regulator of T cell immune responses via interactions with PD-1 and CD80. However, PD-L1 can also act as a positive costimulator, but the relevant counterreceptor not known. We analyzed role in CD8-T to infection Listeria monocytogenes (LM) or vesicular stomatitis virus (VSV). blockade impaired antigen-specific CD8 effector expansion response LM, VSV infection, particularly limiting short-lived differentiation. Simultaneous CD4-T...

10.1371/journal.pone.0056539 article EN cc-by PLoS ONE 2013-02-11

Abstract IFN-producing killer dendritic cells (IKDC) represent a recently discovered cell type in the immune system that possesses number of functions contributing to innate and adaptive immunity, including production 1 2 IFNs, interleukin (IL)-12, natural killing, ultimately antigen presentation naïve T cells. Here, we compared vitro vivo responses mouse IKDC, conventional (DC), (NK) murine cytomegalovirus infection found distinct among these subsets. Upon recognition infected fibroblasts,...

10.1158/0008-5472.can-09-0508 article EN Cancer Research 2009-08-12

Allosteric inhibitors of mitogen-activated protein kinase 1 (MEK1) reveal distinct interactions with MEK1 activation loop residues. The structural analyses will determine whether, and how, suppress the phosphorylation may guide future therapeutic development. In this study, we explored suppression mechanism process in presence MEK allosteric inhibitors, such as selumetinib, trametinib, cobimetinib, CH5126766, by employing molecular dynamics simulations accompanied principal component...

10.1021/acsomega.4c03615 article EN cc-by-nc-nd ACS Omega 2024-07-10

The antiviral effects of hepatitis C virus (HCV)-specific CD8 T cells have been shown in an HCV replicon system but not authentic infectious cell culture (HCVcc) system. Here, we developed tools to examine the antigenicity HCV-infected HLA-A2-positive Huh7.5 hepatoma (Huh7.5A2 cells) activating HCV-specific and downstream effects. Infectious epitope mutants encoding well-defined genotype 1a-derived HLA-A2-restricted NS3-1073 or NS5-2594 were generated from a 2a-derived clone (Jc1Gluc2A) by...

10.1128/jvi.02129-16 article EN Journal of Virology 2017-03-09

Symptoms of chronic hepatitis B (CHB) are not well characterized.To evaluate CHB symptoms and associations with disease activity clinical outcomes.Longitudinal data from 1,576 participants in the Hepatitis Research Network Cohort Study who completed symptom assessments were analyzed. A composite score was calculated using a Symptom Checklist (0=none to 40=extreme). Multivariable mixed models assessed variables associated change over time. Latent class trajectories evaluated. The cumulative...

10.1002/ygh2.458 article EN GastroHep 2021-05-01
Coming Soon ...